Shivam Vashisth
Shivam Vashisth is Principal Regulatory Consultant at Syneos Health.
JournalNavigating the process complexities and challenges associated with EU-CTR transition applications
From 31 January 2025, clinical trials authorised under the old EU Clinical Trial Directive (CTD) must either have ended in the EU/EEA or have been transitioned to new EU Clinical Trial Regulation (CTR). Therefore, any ongoing trial with at least one active site in the EU beyond 30 January 2025 ...